Heterochromatin instability in cancer: From the Barr body to satellites and the nuclear periphery

Seminars in Cancer Biology

Volumn 23, Issue 2, 2013, Pages 99-108

  Carone, Dawn M ^a   Lawrence, Jeanne B ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

BRCA1; Cancer; Epigenetics; Heterochromatin; Satellite DNA; XIST

Indexed keywords

BRCA1 PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; SATELLITE DNA;

BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CENTROMERE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONSTITUTIVE HETEROCHROMATIN; DNA METHYLATION; DNA REPLICATION; EPIGENETICS; EUCHROMATIN; GENE EXPRESSION; GENOMIC INSTABILITY; HETEROCHROMATIN; HISTONE MODIFICATION; HUMAN; NONHUMAN; PLURIPOTENT STEM CELL; REVIEW; SOMATIC CELL; X CHROMATIN; X CHROMOSOME INACTIVATION;

ANIMALS; CELL NUCLEUS; CHROMATIN; EPIGENESIS, GENETIC; GENES, BRCA1; GENOMIC INSTABILITY; HETEROCHROMATIN; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; SEX CHROMATIN;

EID: 84875619696     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2012.06.008     Document Type: Review

References (98)

1. Pienta K.J., Partin A.W., Coffey D.S. Cancer as a disease of DNA organization and dynamic cell structure. Cancer Research 1989, 49:2525-2532.
2. Fischer A.H., Zhao C., Li Q.K., Gustafson K.S., Eltoum I.-E., Tambouret R., et al. The cytologic criteria of malignancy. Journal of Cellular Biochemistry 2010, 110:795-811.
3. Pageau G.J., Hall L.L., Ganesan S., Livingston D.M., Lawrence J.B. The disappearing Barr body in breast and ovarian cancers. Nature Reviews Cancer 2007, 7:628-633.
4. Boisvert F.-M., van Koningsbruggen S., Navascués J., Lamond A.I. The multifunctional nucleolus. Nature Reviews Molecular Cell Biology 2007, 8:574-585.
5. Pederson T., Tsai R.Y.L. In search of nonribosomal nucleolar protein function and regulation. The Journal of Cell Biology 2009, 184:771-776.
6. Spector D. Nuclear bodies. Cell 2006, 127:1020.
7. Dundr M. Nuclear bodies: multifunctional companions of the genome. Current Opinion in Cell Biology 2012, 24:1-8.
8. Lamond A.I., Spector D.L. Nuclear speckles: a model for nuclear organelles. Nature Reviews Molecular Cell Biology 2003, 4:605-612.
9. Hall L.L., Smith K.P., Byron M., Lawrence J.B. Molecular anatomy of a speckle. The Anatomical Record: Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology 2006, 288:664-675.
10. Xing Y., Johnson C.V., Dobner P.R., Lawrence J.B. Higher level organization of individual gene transcription and RNA splicing. Science 1993, 259:1326-1330.
11. Jackson D.A. The amazing complexity of transcription factories. Briefings in Functional Genomics and Proteomics 2005, 4:143-157.
12. Osborne C.S., Chakalova L., Mitchell J.A., Horton A., Wood A.L., Bolland D.J., et al. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biology 2007, 5:e192.
13. Göndör A., Ohlsson R. Chromosome crosstalk in three dimensions. Nature 2009, 461:212-217.
14. Lawrence J.B., Clemson C.M. Gene associations: true romance or chance meeting in a nuclear neighborhood?. The Journal of Cell Biology 2008, 182:1035-1038.
15. Brown J.M. Coregulated human globin genes are frequently in spatial proximity when active. The Journal of Cell Biology 2006, 172:177-187.
16. Shopland L.S., Johnson C.V., Byron M., McNeil J., Lawrence J.B. Clustering of multiple specific genes and gene-rich R-bands around SC-35 domains: evidence for local euchromatic neighborhoods. Journal of Cell Biology 2003, 162:981-990.
17. Chuang C.-H., Belmont A.S. Close encounters between active genes in the nucleus. Genome Biology 2005, 6:237.
18. Guelen L., Pagie L., Brasset E., Meuleman W., Faza M.B., Talhout W., et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008, 453:948.
19. Reddy K.L., Zullo J.M., Bertolino E., Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 2008, 452:243.
20. Kumaran R.I., Spector D.L. A genetic locus targeted to the nuclear periphery in living cells maintains its transcriptional competence. The Journal of Cell Biology 2008, 180:51-65.
21. Hansen K.D., Timp W., Bravo H.C., Sabunciyan S., Langmead B., Mcdonald O.G., et al. Increased methylation variation in epigenetic domains across cancer types. Nature Genetics 2011, 43:768-775.
22. Kruhlak M.J., Lever M.A., Fischle W., Verdin E., Bazett-Jones D.P., Hendzel M.J. Reduced mobility of the alternate splicing factor (ASF) through the nucleoplasm and steady state speckle compartments. Journal of Cell Biology 2000, 150:41-51.
23. Phair R.D., Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 2000, 404:604-609.
24. Shopland L.S. Seeking common ground in nuclear complexity. The Journal of Cell Biology 2000, 150:1F-4F.
25. Moen P.T., Johnson C.V., Byron M., Shopland L.S., de la Serna I.L., Imbalzano A.N., et al. Repositioning of muscle-specific genes relative to the periphery of SC-35 domains during skeletal myogenesis. Molecular Biology of the Cell 2004, 15:197-206.
26. Hu Y., Plutz M., Belmont A.S. Hsp70 gene association with nuclear speckles is Hsp70 promoter specific. The Journal of Cell Biology 2010, 191:711-719.
27. Hager G.L., Nagaich A.K., Johnson T.A., Walker D.A., John S. Dynamics of nuclear receptor movement and transcription. Biochimica et Biophysica Acta (BBA): Gene Structure and Expression 2004, 1677:46-51.
28. Moen P., Smith K., Lawrence J. Compartmentalization of specific pre-mRNA metabolism: an emerging view. Human Molecular Genetics 1995, 4 Spec No:1779-1789.
29. Misteli T. The concept of self-organization in cellular architecture. The Journal of Cell Biology 2001, 155:181-186.
30. Rajendra T.K., Praveen K., Matera A.G. Genetic analysis of nuclear bodies: from nondeterministic chaos to deterministic order. Cold Spring Harbor Symposia on Quantitative Biology 2011, 75:365-374.
31. Nickerson J. Experimental observations of a nuclear matrix. Journal of Cell Science 2001, 114:463-474.
32. Cook P.R., Brazell I.A. Supercoils in human DNA. Journal of Cell Science 1975, 19:261-279.
33. Vogelstein B., Pardoll D.M., Coffey D.S. Supercoiled loops and eukaryotic DNA replication. Cell 1980, 22:79-85.
34. Gerdes M.G., Carter K.C., Moen P.T., Lawrence J.B. Dynamic changes in the higher-level chromatin organization of specific sequences revealed by in situ hybridization to nuclear halos. The Journal of Cell Biology 1994, 126:289-304.
35. Linnemann A.K., Krawetz S.A. Maintenance of a functional higher order chromatin structure: the role of the nuclear matrix in normal and disease states. Gene Therapy & Molecular Biology 2009, 13:231.
36. Zink D., Fischer A.H., Nickerson J.A. Nuclear structure in cancer cells. Nature Reviews Cancer 2004, 4:677.
37. Heng H.H.Q., Goetze S., Ye C.J., Liu G., Stevens J.B., Bremer S.W., et al. Chromatin loops are selectively anchored using scaffold/matrix-attachment regions. Journal of Cell Science 2004, 117:999-1008.
38. Linnemann A.K., Krawetz S.A. Silencing by nuclear matrix attachment distinguishes cell-type specificity: association with increased proliferation capacity. Nucleic Acids Research 2009, 37:2779-2788.
39. Han H.J., Russo J., Kohwi Y., Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008, 452:187-193.
40. Butler J.T., Hall L.L., Smith K.P., Lawrence J.B. Changing nuclear landscape and unique PML structures during early epigenetic transitions of human embryonic stem cells. Journal of Cellular Biochemistry 2009, 107:609-621.
41. Meshorer E., Yellajoshula D., George E., Scambler P.J., Brown D.T., Misteli T. Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Developmental Cell 2006, 10:105-116.
42. Seeler J.S., Dejean A. The PML nuclear bodies: actors or extras?. Current Opinion in Genetics and Development 1999, 9:362-367.
43. Luciani J.J., Depetris D., Usson Y., Metzler-Guillemain C., Mignon-Ravix C., Mitchell M.J., et al. PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. Journal of Cell Science 2006, 119:2518-2531.
44. Marahrens Y., Panning B., Dausman J., Strauss W., Jaenisch R. Xist-deficient mice are defective in dosage compensation but not spermatogenesis. Genes & Development 1997, 11:156-166.
45. Clemson C.M., McNeil J.A., Willard H.F., Lawrence J.B. XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. Journal of Cell Biology 1996, 132:259-275.
46. Brown C., Hendrich B., Rupert J., Lafreniere R. The human XIST gene: analysis of a 17kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 1992, 78. 10.1016/0092-8674(92)90520-M.
47. Brockdorff N., Ashworth A., Kay G.F., McCabe V.M., Norris D.P., Cooper P.J., et al. The product of the mouse Xist gene is a 15kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell 1992, 71:515-526.
48. Heard E. Delving into the diversity of facultative heterochromatin: the epigenetics of the inactive X chromosome. Current Opinion in Genetics and Development 2005, 15:482-489.
49. Boumil R.M., Lee J.T. Forty years of decoding the silence in X-chromosome inactivation. Human Molecular Genetics 2001, 10:2225-2232.
50. Hall L.L., Lawrence J.B. XIST RNA and architecture of the inactive X chromosome: implications for the repeat genome. Cold Spring Harbor Symposia on Quantitative Biology 2010, 75:345-356.
51. Csankovszki G., Nagy A., Jaenisch R. Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. The Journal of Cell Biology 2001, 153:773-784.
52. Hall L.L., Clemson C.M., Byron M., Wydner K., Lawrence J.B. Unbalanced X; autosome translocations provide evidence for sequence specificity in the association of XIST RNA with chromatin. Human Molecular Genetics 2002, 11:3157-3165.
53. Brown C.J., Willard H.F. The human X-inactivation centre is not required for maintenance of X-chromosome inactivation. Nature 1994, 368:154-156.
54. Barr M. Chromosomes, sex chromatin, and cancer. Proceedings. Canadian Cancer Conference 1957, 2:3-16.
55. Borah V., Shah P.N., Ghosh S.N., Sampat M.B., Jussawalla D.J. Further studies on the prognostic importance of Barr body frequency in human breast cancer: with discussion on its probable mechanism. Journal of Surgical Oncology 1980, 13:1-7.
56. Richardson A.L., Wang Z.C., De Nicolo A., Lu X., Brown M., Miron A., et al. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132.
57. Kawakami T., Zhang C., Taniguchi T., Kim C.J., Okada Y., Sugihara H., et al. Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells. Oncogene 2004, 23:6163-6169.
58. Jazaeri A.A., Yee C.J., Sotiriou C., Brantley K.R., Boyd J., Liu E.T. Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. Journal of the National Cancer Institute 2002, 94:990-1000.
59. Sirchia S.M. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells. Cancer Research 2005, 65:2139-2146.
60. Benoît M., Hudson T., Maire G., Squire J., Arcand S., Provencher D., et al. Global analysis of chromosome X gene expression in primary cultures of normal ovarian surface epithelial cells and epithelial ovarian cancer cell lines. International Journal of Oncology 2007, 30:5-17.
61. Pageau G.J., Hall L.L., Lawrence J.B. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin. Journal of Cellular Biochemistry 2007, 100:835-850.
62. Sirchia S., Tabano S., Monti L., Recalcati M. Misbehaviour of XIST RNA in breast cancer cells. PLoS One 2009, 4(5):e5559.
63. Vincent-Salomon A., Ganem-Elbaz C., Manié E., Raynal V., Sastre-Garau X., Stoppa-Lyonnet D., et al. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors. Cancer Research 2007, 67:5134-5140.
64. Ganesan S., Silver D.P., Greenberg R.A., Avni D., Drapkin R., Miron A., et al. BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell 2002, 111:393-405.
65. Gudmundsdottir K., Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006, 25:5864-5874.
66. Mullan P.B., Quinn J.E., Harkin D.P. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 2006, 25:5854-5863.
67. Gorski J.J., Savage K.I., Mulligan J.M., McDade S.S., Blayney J.K., Ge Z., et al. Profiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis. Nucleic Acids Research 2011, 39:9536-9548.
68. Meraldi P., Honda R., Nigg E. Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Current Opinion in Genetics and Development 2004, 14:29-36.
69. Hall L.L., Byron M., Pageau G., Lawrence J.B. AURKB-mediated effects on chromatin regulate binding versus release of XIST RNA to the inactive chromosome. The Journal of Cell Biology 2009, 186:491-507.
70. Huen M.S.Y., Sy S.M.H., Chen J. BRCA1 and its toolbox for the maintenance of genome integrity. Nature Reviews Molecular Cell Biology 2010, 11:138-148.
71. Xiao C., Sharp J., Kawahara M., Davalos A. The XIST noncoding RNA functions independently of BRCA1 in X inactivation. Cell 2007, 128:977-989.
72. Pageau G.J., Lawrence J.B. BRCA1 foci in normal S-phase nuclei are linked to interphase centromeres and replication of pericentric heterochromatin. Journal of Cell Biology 2006, 175:693-701.
73. Quivy J.-P., Roche D., Kirschner D., Tagami H., Nakatani Y., Almouzni G. A CAF-1 dependent pool of HP1 during heterochromatin duplication. The EMBO Journal 2004, 23:3516-3526.
74. Lou Z., Minter-Dykhouse K., Chen J. BRCA1 participates in DNA decatenation. Nature Structural & Molecular Biology 2005, 12:589-593.
75. Zhu Q., Pao G.M., Huynh A.M., Suh H., Tonnu N., Nederlof P.M., et al. BRCA1 tumour suppression occurs via heterochromatin-mediated silencing. Nature 2011, 477:179-184.
76. Sankaran S., Starita L.M., Groen A.C., Ko M.J., Parvin J.D. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Molecular and Cellular Biology 2005, 25:8656-8668.
77. Thompson S.L., Bakhoum S.F., Compton D.A. Mechanisms of chromosomal instability. Current Biology 2010, 20:R285-R295.
78. Slee R.B., Steiner C.M., Herbert B.-S., Vance G.H., Hickey R.J., Schwarz T., et al. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability. Oncogene 2011, 1-10.
79. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009, 1:239-259.
80. Narayan A., Ji W., Zhang X.Y., Marrogi A., Graff J.R., Baylin S.B., et al. Hypomethylation of pericentromeric DNA in breast adenocarcinomas. International Journal of Cancer 1998, 77:833-838.
81. Ji W., Hernandez R., Zhang X.Y., Qu G.Z., Frady A., Varela M., et al. DNA demethylation and pericentromeric rearrangements of chromosome 1. Mutation Research 1997, 379:33-41.
82. Prada D., González R., Sánchez L., Castro C., Fabián E., Herrera L.A. Satellite 2 demethylation induced by 5-azacytidine is associated with missegregation of chromosomes 1 and 16 in human somatic cells. Mutation Research 2012, 729:100-105.
83. Hansen R.S. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proceedings of the National Academy of Sciences 1999, 96:14412-14417.
84. Barki-Celli L., Lefebvre C., Le Baccon P., Nadeau G., Bonnefoix T., Usson Y., et al. Differences in nuclear positioning of 1q12 pericentric heterochromatin in normal and tumor B lymphocytes with 1q rearrangements. Genes, Chromosomes and Cancer 2005, 43:339-349.
85. Pandis N., Teixeira M.R., Gerdes A.M., Limon J., Bardi G., Andersen J.A., et al. Chromosome abnormalities in bilateral breast carcinomas. Cytogenetic evaluation of the clonal origin of multiple primary tumors. Cancer 1995, 76:250-258.
86. Mertens F., Johansson B., Höglund M., Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Research 1997, 57:2765-2780.
87. Ting D.T., Lipson D., Paul S., Brannigan B.W., Akhavanfard S., Coffman E.J., et al. Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011, 331:593-596.
88. Eymery A., Horard B., Atifi-Borel El M., Fourel G., Berger F., Vitte A.-L., et al. A transcriptomic analysis of human centromeric and pericentric sequences in normal and tumor cells. Nucleic Acids Research 2009, 37:6340-6354.
89. Small D., Nelkin B., Vogelstein B. Nonrandom distribution of repeated DNA sequences with respect to supercoiled loops and the nuclear matrix. Proceedings of the National Academy of Sciences of the United States of America 1982, 79:5911-5915.
90. Platts A.E., Quayle A.K., Krawetz S.A. In-silico prediction and observations of nuclear matrix attachment. Cellular and Molecular Biology Letters 2006, 11:191-213.
91. Zaidi S.K., Young D.W., Javed A., Pratap J., Montecino M., van Wijnen A., et al. Nuclear microenvironments in biological control and cancer. Nature Reviews Cancer 2007, 7:454-463.
92. Feinberg A.P., Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 1983, 301:89-92.
93. Hall L.L., Byron M., Sakai K., Carrel L., Willard H.F., Lawrence J.B. An ectopic human XIST gene can induce chromosome inactivation in postdifferentiation human HT-1080 cells. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:8677-8682.
94. Britten R., Kohne D. Repeated Sequences in DNA. Science 1968, 161:529-540.
95. Easwaran H.P., Van Neste L., Cope L., Sen S., Mohammad H.P., Pageau G.J., et al. Aberrant silencing of cancer-related genes by CpG hypermethylation occurs independently of their spatial organization in the nucleus. Cancer Research 2010, 70:8015-8024.
96. Sharma S., Kelly T.K., Jones P.A. Epigenetics in cancer. Carcinogenesis 2010, 31:27-36.
97. Gerlinger M., Rowan A.J., Horswell S., Larkin J., Endesfelder D., Gronroos E., et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New England Journal of Medicine 2012, 366:883-892.
98. Spencer V.A., Xu R., Bissell M.J. Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. Advances in Cancer Research 2007, 275-294.